Advancing a Brain-Targeted AAV Gene Therapy for Alzheimer’s Disease
- Evaluating functional RNA silencing in the brain
- Advancing brain-targeted viral vector design
- Exploring the path from preclinical success to clinical impact
December 1-3, 2026 | Boston, MA